• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷霉素氨丁三醇与其他化疗药物相比对细菌黏附的影响。

Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents.

作者信息

Carlone N A, Borsotto M, Cuffini A M, Savoia D

出版信息

Eur Urol. 1987;13 Suppl 1:86-91. doi: 10.1159/000472869.

DOI:10.1159/000472869
PMID:3552703
Abstract

The effect of fosfomycin trometamol in comparison with that of norfloxacin and co-trimoxazole on the hemagglutination, yeast cell aggregation and adhesive properties of both gram-positive and gram-negative microorganisms was studied. The strains were isolated from the urine of patients with urinary tract infections, or from vaginal swabs. At sublethal concentrations (1/4 and 1/8 of the minimal inhibitory concentration), the ability of the bacteria to adhere to human uroepithelial cells was reduced by any of the 3 drugs assayed. The reduction corresponded to a decrease in the agglutinating activity of the gram-negative bacteria tested, such providing further evidence for the efficacy of the different chemoantibiotics. In particular, fosfomycin trometamol and norfloxacin proved to be more effective than co-trimoxazole in affecting the adhesive properties of all the strains employed.

摘要

研究了磷霉素氨丁三醇与诺氟沙星和复方新诺明相比,对革兰氏阳性和革兰氏阴性微生物的血凝、酵母细胞聚集及黏附特性的影响。这些菌株从尿路感染患者的尿液或阴道拭子中分离得到。在亚致死浓度(最低抑菌浓度的1/4和1/8)下,所检测的3种药物中的任何一种都能降低细菌黏附人尿道上皮细胞的能力。这种降低与所检测的革兰氏阴性菌凝集活性的下降相对应,从而为不同化学抗生素的疗效提供了进一步证据。特别是,磷霉素氨丁三醇和诺氟沙星在影响所有所用菌株的黏附特性方面比复方新诺明更有效。

相似文献

1
Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents.磷霉素氨丁三醇与其他化疗药物相比对细菌黏附的影响。
Eur Urol. 1987;13 Suppl 1:86-91. doi: 10.1159/000472869.
2
[Comparative activity of norfloxacin and other chemotherapeutic agents on the adhesion of bacteria of the uro-vaginal tract to uroepithelial cells].[诺氟沙星与其他化疗药物对泌尿生殖道细菌黏附于尿道上皮细胞的比较活性]
G Batteriol Virol Immunol. 1985 Jul-Dec;78(7-12):185-204.
3
Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
Chemioterapia. 1986 Aug;5(4):268-72.
4
A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.单剂量磷霉素氨丁三醇(蒙诺力)与5天疗程甲氧苄啶治疗女性单纯性下尿路感染的比较。
Int J Antimicrob Agents. 1998 Apr;10(1):39-47. doi: 10.1016/s0924-8579(98)00021-1.
5
Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.在膀胱体外模型中,磷霉素氨丁三醇在人尿液中的抗菌活性。
Chemioterapia. 1988 Feb;7(1):15-9.
6
In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens.磷霉素氨丁三醇对泌尿系统病原体抗菌活性的体外测试
Chemioterapia. 1988 Feb;7(1):10-4.
7
Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
Chemioterapia. 1986 Aug;5(4):278-82.
8
Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazole.女性急性单纯性下尿路感染病原体的谱型、药敏情况及其与磷霉素氨丁三醇单剂量治疗和氧氟沙星/复方新诺明治疗后细菌学结果的相关性
Infection. 1992;20 Suppl 4:S296-301. doi: 10.1007/BF01710018.
9
Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.诺氟沙星与复方新诺明治疗男性复发性尿路感染的对比研究
Scand J Infect Dis Suppl. 1986;48:48-53.
10
Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol.用单剂量磷霉素氨丁三醇治疗大鼠实验性膀胱炎。
Chemioterapia. 1988 Feb;7(1):24-8.

引用本文的文献

1
Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?对常用于治疗耐抗生素革兰氏阳性病原体的分子的抗生素耐药性:临床医生应关注什么?
Pathogens. 2024 Jan 19;13(1):88. doi: 10.3390/pathogens13010088.
2
Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a Spanish multicenter cohort.口服磷霉素治疗肾移植受者无症状菌尿的疗效与安全性:一项西班牙多中心队列研究结果
Antimicrob Agents Chemother. 2023 May 1;95(5). doi: 10.1128/AAC.02267-20. Epub 2021 Feb 8.
3
Antibacterial effect of fosfomycin tromethamine on the bacteria inside urinary infection stones.
磷霉素氨丁三醇对尿路感染结石内细菌的抗菌作用。
Int Urol Nephrol. 2020 Apr;52(4):645-654. doi: 10.1007/s11255-019-02358-0. Epub 2019 Dec 12.
4
Oral and intravenous fosfomycin in complicated urinary tract infections.口服和静脉注射磷霉素治疗复杂性尿路感染
Rev Esp Quimioter. 2019 May;32 Suppl 1(Suppl 1):37-44.
5
Fosfomycin.磷霉素
Clin Microbiol Rev. 2016 Apr;29(2):321-47. doi: 10.1128/CMR.00068-15.
6
Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7.肠粘连的亚型内变异导致上皮屏障破坏的差异,并与芽囊原虫7型对甲硝唑的耐药性相关。
PLoS Negl Trop Dis. 2014 May 22;8(5):e2885. doi: 10.1371/journal.pntd.0002885. eCollection 2014 May.
7
Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.磷霉素氨丁三醇:单剂量口服治疗急性下尿路感染及无症状菌尿孕妇的应用评价。
Drugs. 2013 Nov;73(17):1951-66. doi: 10.1007/s40265-013-0143-y.
8
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.大肠杆菌中磷霉素耐药性的生物学代价及机制
Antimicrob Agents Chemother. 2003 Sep;47(9):2850-8. doi: 10.1128/AAC.47.9.2850-2858.2003.
9
Optimal characteristics of agents to treat uncomplicated urinary tract infections.治疗单纯性尿路感染药物的最佳特性。
Infection. 1992;20 Suppl 4:S266-71. doi: 10.1007/BF01710012.